Valuation: Procter & Gamble Health Limited

Market Cap 11TCr 117.08Cr 102.62Cr 95Cr 88Cr 165.03Cr 167.02Cr 1.13TCr 444.08Cr 5.53TCr 439.49Cr 430.03Cr 19TCr P/E 2026
24.4x
P/E 2027 * 29.4x
Enterprise Value 11TCr 117.08Cr 102.62Cr 95Cr 88Cr 165.03Cr 167.02Cr 1.13TCr 444.08Cr 5.53TCr 439.49Cr 430.03Cr 19TCr EV / Sales 2026
5.66x
EV / Sales 2027 * 7.05x
Free-Float
47.81%
Yield 2026 *
-
Yield 2027 * 1.74%
1 day-0.81%
1 week-1.04%
Current month+7.34%
1 month+8.31%
3 months+33.67%
6 months+24.72%
Current year+19.15%
1 week 6,740
Extreme 6740
6,955
1 month 6,190.85
Extreme 6190.85
6,955
Current year 4,699.7
Extreme 4699.7
6,955
1 year 4,699.7
Extreme 4699.7
6,955
3 years 4,640.3
Extreme 4640.3
6,955
5 years 3,883
Extreme 3883
6,955
10 years 681
Extreme 681
7,499.95
Manager TitleAgeSince
Chief Executive Officer 57 01/04/2018
Director of Finance/CFO - 01/10/2025
Chief Tech/Sci/R&D Officer - 01/09/2025
Director TitleAgeSince
Director/Board Member - 01/04/2025
Chairman 69 01/04/2025
Director/Board Member 57 01/04/2018
Change 5-day change 1-year change 3-year change Capi.($)
-0.81%-1.04%+15.69%+31.65% 117.88Cr
+0.28%+2.11%+15.84%+78.74% 4.87TCr
+0.73%+1.09%+68.36%+113.49% 3.55TCr
-0.63%+0.41%-3.36%+35.58% 1.21TCr
-0.51%+1.04%+17.25%+85.10% 1.19TCr
+0.75%+0.94%+34.42%+136.73% 924.7Cr
-1.18%-0.15%+49.86%-5.31% 701.14Cr
-1.26%-2.08%+14.59%+33.48% 686.4Cr
-.--%+0.14% - - 678.76Cr
+0.12%-2.57%+0.75%+202.72% 655.38Cr
Average -0.20%+0.11%+23.71%+79.13% 1.46TCr
Weighted average by Cap. +0.13%+0.37%+29.90%+87.25%

Financials

2026 2027 *
Net sales 1.35TCr 14Cr 12Cr 11Cr 10Cr 20Cr 20Cr 136.04Cr 53Cr 662.45Cr 53Cr 52Cr 2.29TCr 1.6TCr 17Cr 15Cr 13Cr 12Cr 23Cr 24Cr 160.94Cr 63Cr 783.69Cr 62Cr 61Cr 2.71TCr
Net income 314.7Cr 3.27Cr 2.86Cr 2.65Cr 2.44Cr 4.61Cr 4.66Cr 32Cr 12Cr 154.23Cr 12Cr 12Cr 532.52Cr 382.95Cr 3.98Cr 3.49Cr 3.23Cr 2.97Cr 5.6Cr 5.67Cr 39Cr 15Cr 187.68Cr 15Cr 15Cr 648.01Cr
Net Debt - -
Logo Procter & Gamble Health Limited
Procter & Gamble Health Limited is an India-based multinational consumer goods company. The Company is focused on manufacturing and marketing of over-the-counter products, vitamins, minerals, and supplements products for a healthy lifestyle. The Company is engaged in the manufacturing and selling of healthcare products, such as vitamins, minerals and supplements. Patients are end consumers of the products. The Company’s distribution channels (direct and indirect), inter alia, include distributors, health care professionals, pharmacies and chemists. The Company’s brands include Polybion, Cosome, Evion, Neurobion, Seven Seas, Nasivion, and Livogen. Cosome is a medicine which is used to help relieve dry coughs and related congestion symptoms. Evion is a Vitamin E capsules. The Seven Seas is a pure vitamin rich cod-liver oil. Neurobion offers a range of neurotropic supplements. Its products are sold in about 180 countries and territories throughout the world.
Employees
1,326
Date Price Change Volume
21/26/21 6,792.75 -0.81% 382
20/26/20 ₹6,847.90 +0.74% 10,657
17/26/17 ₹6,797.90 -0.76% 158
16/26/16 ₹6,850.00 -0.41% 17,719
15/26/15 ₹6,877.95 -0.53% 14,343
Trader
-
Investor
-
Global
-
Quality
-
ESG MSCI
BB

Annual profits - Rate of surprise

  1. Stock Market
  2. Stocks
  3. PGHL Stock